Group 1 - Mawer Investment Management Ltd notified Fagron on 11 March 2026 that its shareholding has decreased below the 3% disclosure threshold due to a disposal of voting securities [1][8] - As of 10 March 2026, Mawer Investment Management Ltd holds 2,188,313 shares in Fagron, which corresponds to 2.97% of the total voting rights based on 73,668,904 outstanding voting rights [8] - Fagron is a leading global company in pharmaceutical compounding, providing personalized medicine to various healthcare facilities in over 38 countries [3][4] Group 2 - Fagron is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [4] - The operational activities of Fagron are managed through its Dutch subsidiary, Fagron BV, headquartered in Rotterdam [4] - The full transparency notification from Mawer Investment Management Ltd is accessible on Fagron's website [8]
Disclosure of a transparency notification from Mawer Investment Management Ltd
Globenewswire·2026-03-13 17:00